Status:
COMPLETED
Insulin Sensitizers Role in Control of PCOS Vicious Cycle.
Lead Sponsor:
Zagazig University
Conditions:
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
PCOS is a common and complex disease affecting women of reproductive age. It is characterized by its complex pathological symptoms and mechanisms resulting in endocrine and metabolic dysfunction. PCOS...
Eligibility Criteria
Inclusion
- Age;
- Residence;
- level of education \& type of work;
- Marital and fertility statuses, and if infertility was the main complaint;
- Presence of risk factors as sedentary lifestyle;
- Emotional stress and family history of PCOS;
- Obesity-related medical disorders especially DM or MAFLD;
- History of previous treatment for PCOS and its outcomes;
- Menstrual pattern such as infrequent menstrual periods.
Exclusion
- Women had other manifestations of metabolic syndrome:
- Cardiac manifestations of PCOS;
- Maintained on other therapies or prepared for /received laparoscopic intervention for PCOS;
- Receiving scheduled exercise, lipid-lowering therapies, or maintained on diabetogenic drugs for any other indications;
- Had morbid obesity with body mass index (BMI) \>35 kg/m2;
- Causes other than PCOS for infertility, manifest DM, hepatic or pancreatic diseases.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2023
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT06170463
Start Date
August 1 2022
End Date
April 15 2023
Last Update
December 20 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zagazig university
Zagazig, Ash Sharqia Governorate, Egypt, 44519